Clinical Trial Update: Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study results for hexaminolevulinate-based photodynamic therapy to treat cervical intraepithelial neoplasia, completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Hexaminolevulinate (hexaminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED | Results posted: 2014-08-21